This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 119/3/436    most recent CIRCULATIONAHA.108.783506v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schmitt, J. P. Articles by Lohse, M. J. Search for Related Content PubMed PubMed Citation Articles by Schmitt, J. P. Articles by Lohse, M. J. Related Collections Animal models of human disease Calcium cycling/excitation-contraction coupling Genetically altered mice Myocardial cardiomyopathy disease Related Article

(Circulation. 2009;119:436-444.)
© 2009 American Heart Association, Inc.

Molecular Cardiology

Alterations of Phospholamban Function Can Exhibit Cardiotoxic Effects Independent of Excessive Sarcoplasmic Reticulum Ca²⁺-ATPase Inhibition

Joachim P. Schmitt, MD; Ferhaan Ahmad, MD, PhD; Kristina Lorenz, PhD; Lutz Hein, MD; Stefan Schulz, MD; Michio Asahi, MD, PhD; David H. MacLennan, PhD; Christine E. Seidman, MD; J.G. Seidman, PhD; Martin J. Lohse, MD

From the Institute of Pharmacology and Toxicology, University of Würzburg, Würzburg, Germany (J.P.S., K.L., L.H., M.J.L.); Cardiovascular Institute, University of Pittsburgh, Pittsburgh, Pa (F.A.); Institute of Pharmacology and Toxicology, University of Freiburg, Freiburg, Germany (L.H.); Institute of Pharmacology and Toxicology, University of Jena, Jena, Germany (S.S.); Banting and Best Department of Medical Research, University of Toronto, Toronto, Ontario, Canada (M.A., D.H.M.); Cardiovascular Division, Brigham and Women’s Hospital, Boston, Mass (C.E.S.); and Department of Genetics, Harvard Medical School, Boston, Mass (F.A., C.E.S., J.G.S.).

Correspondence to Joachim P. Schmitt, Institute of Pharmacology and Toxicology, University of Würzburg, Versbacher Str 9, 97078 Würzburg, Germany. E-mail schmitt{at}toxi.uni-wuerzburg.de

Received March 31, 2008; accepted November 7, 2008.

Background— Low activity of the sarco(endo)plasmic reticulum Ca²⁺-ATPase (SERCA2a) resulting from strong inhibition by phospholamban (PLN) can depress cardiac contractility and lead to dilated cardiomyopathy and heart failure. Here, we investigated whether PLN exhibits cardiotoxic effects via mechanisms other than chronic inhibition of SERCA2a by studying a PLN mutant, PLN^R9C, that triggers cardiac failure in humans and mice.

Methods and Results— Because PLN^R9C inhibits SERCA2a mainly by preventing deactivation of wild-type PLN, SERCA2a activity could be increased stepwise by generating mice that carry a PLN^R9C transgene and 2, 1, or 0 endogenous PLN alleles (PLN^+/++TgPLN^R9C, PLN^+/–+TgPLN^R9C, and PLN^–/–+TgPLN^R9C, respectively). PLN^–/– +TgPLN^R9C hearts demonstrated accelerated sarcoplasmic reticulum Ca²⁺ uptake rates and improved hemodynamics compared with PLN^+/++TgPLN^R9C mice but still responded poorly to β-adrenergic stimulation because PLN^R9C impairs protein kinase A–mediated phosphorylation of both wild-type and mutant PLN. PLN^+/++TgPLN^R9C mice died of heart failure at 21±6 weeks, whereas heterozygous PLN^+/–+TgPLN^R9C mice survived to 48±11 weeks, PLN^–/–+TgPLN^R9C mice to 66±19 weeks, and wild-type mice to 94±27 weeks (P<0.001). Although Ca²⁺ reuptake kinetics in young PLN^–/–+TgPLN^R9C mice exceeded those measured in wild-type control animals, this parameter alone was not sufficient to prevent the eventual development of dilated cardiomyopathy.

Conclusions— The data demonstrate an association between the dose-dependent inhibition of SERCA2a activity by PLN^wt and the time of onset of heart failure and show that a weak inhibitor of SERCA2a, PLN^R9C, which is diminished in its ability to modify the level of SERCA2a activity, leads to heart failure despite fast sarcoplasmic reticulum Ca²⁺ reuptake.

---

 

CLINICAL PERSPECTIVE

Related Article:

Clinical Summaries
Circulation 2009 119: 359-361. [Extract] [Full Text]

This article has been cited by other articles:

				I. Vandecaetsbeek, M. Trekels, M. De Maeyer, H. Ceulemans, E. Lescrinier, L. Raeymaekers, F. Wuytack, and P. Vangheluwe Structural basis for the high Ca2+ affinity of the ubiquitous SERCA2b Ca2+ pump PNAS, November 3, 2009; 106(44): 18533 - 18538. [Abstract] [Full Text] [PDF]